Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 2 Butanol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN118685468A reveals a novel enzymatic route for high-purity chiral amino alcohol production, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Patent CN120441446A details a novel crystallization method for 2-Amino-2-Methyl-Propanol purification ensuring pharmaceutical grade quality and supply chain stability for global buyers.
Patent CN113214169B reveals a mild, high-yield route for pyrazine intermediates. Discover cost-effective manufacturing strategies for pulmonary hypertension drugs.
Patent CN101328110B details a stable THF-based Grignard route for 1-chloro-4-(4-chlorophenyl)-2-butanol, offering superior safety and yield for antifungal API manufacturing.
Patent CN100344766C details a cost-effective enzymatic resolution of 2-methyl-1-butanol using vinyl acetate, offering significant supply chain advantages for pharmaceutical intermediates.
Patent CN105481703A enables high-purity S-2-aminobutanol via catalytic hydrogenation. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Novel synthesis of Aliskiren intermediate via etherification and enzymatic resolution. Reduces steps and cost for API manufacturing significantly.
Patent CN110256261B details a novel copper-coordinated chiral resolution method for high-purity L-2-amino-1-butanol, offering significant supply chain and cost advantages.
Patent CN100567497C details a novel two-phase enzymatic route for high-purity chiral 2-butanol. This method offers significant supply chain stability and cost reduction advantages.
Patent CN103483201A details a novel asymmetric synthesis of (R)-2-methyl-4-nitro-1-butanol, eliminating racemic resolution for significant cost reduction and improved supply chain efficiency.
Novel biocatalytic method for (S)-2-amino-1-butanol and (R)-3-amino-1-butanol using amine dehydrogenases. High yield, mild conditions, scalable process for pharmaceutical intermediates.
Discover a safe, high-yield synthesis for β-trifluoromethyl-2-methylene cyclopentanone. Reduce EHS risks and scale production with our CDMO expertise.